Evidence supporting ETI therapy for N1303K CFTR variant patients
Publisher：Unknown
·Published at: 2025-12-14
I am looking for information regarding the evidence that supports the use of Elexacaftor+Tezacaftor+Ivacaftor (ETI) therapy specifically for patients with the N1303K CFTR variant.
Loading...